StemCells makes controversial board appointment
This article was originally published in Clinica
Executive Summary
The California Institute of Regenerative Medicine (CIRM) has launched an internal review after Newark, California-based StemCells appointed the state stem cell agency's former president Alan Trounson to the company's board of directors. CIRM was established to oversee the distribution of grants and loans for stem cell research, which are financed by $3bn in California bond sales that were authorized by a majority of California voters who approved Proposition 71 in 2004.